Press "Enter" to skip to content

FDA approves new treatment for adult patients with rare, life-threatening blood disease

The FDA approved Ultomiris (ravulizumab) injection for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH), a rare and life-threatening blood disease.

Original source: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm629022.htm

Also Read:   FDA approves first live, non-replicating vaccine to prevent smallpox and monkeypox